Advertisement
Advertisement
PHG
KONINKLIJKE PHILIPS N.V.
27.77
USDSponsored
-0.49
-1.72%
Mar 13, 15:59 UTC -4
Closed
After-Market
27.87
+0.09
+0.34%
PHG Earnings Reports
Positive Surprise Ratio
PHG beat 21 of 40 last estimates.
53%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$3.98B
/$0.21
Implied change from Q4 25 (Revenue/ EPS)
-21.83%
/-58.00%
Implied change from Q1 25 (Revenue/ EPS)
-2.75%
/-16.00%
KONINKLIJKE PHILIPS N.V. earnings per share and revenue
On Feb 10, 2026, PHG reported earnings of 0.50 USD per share (EPS) for Q4 25, beating the estimate of 0.48 USD, resulting in a 3.95% surprise. Revenue reached 5.10 billion, compared to an expected 5.14 billion, with a -0.86% difference. The market reacted with a +11.11% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 4 analysts forecast an EPS of 0.21 USD, with revenue projected to reach 3.98 billion USD, implying an decrease of -58.00% EPS, and decrease of -21.83% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
BillionToOne, Inc. Class A Common Stock
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.08
Actual
$0.11
Surprise
+27.02%
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Brainsway Ltd. - ADR
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.13
Actual
$0.14
Surprise
+6.63%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
Apyx Medical Corporation Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.63%
MacroGenics, Inc.
Report Date
Mar 09, 2026 For Q4 25
Estimate
-$0.29
Actual
-$0.23
Surprise
+22.40%
Biote Corp. Class A Common Stock
Report Date
Mar 11, 2026 For Q4 25
Estimate
$0.05
Actual
$0.06
Surprise
+17.65%
Exagen Inc. Common Stock
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.20
Surprise
-4.22%
Immucell Corp
Report Date
Mar 04, 2026 For Q4 25
Estimate
-Actual
-$0.31
Surprise
-
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
FAQ
What were KONINKLIJKE PHILIPS N.V.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, KONINKLIJKE PHILIPS N.V. reported EPS of $0.50, beating estimates by 3.95%, and revenue of $5.10B, -0.86% below expectations.
How did the market react to KONINKLIJKE PHILIPS N.V.'s Q4 2025 earnings?
The stock price moved up 11.11%, changed from $29.62 before the earnings release to $32.91 the day after.
When is KONINKLIJKE PHILIPS N.V. expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for KONINKLIJKE PHILIPS N.V.'s next earnings report?
Based on 4
analysts, KONINKLIJKE PHILIPS N.V. is expected to report EPS of $0.21 and revenue of $3.98B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement